Correlation Between Eyepoint Pharmaceuticals and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eyepoint Pharmaceuticals and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyepoint Pharmaceuticals and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyepoint Pharmaceuticals and Checkpoint Therapeutics, you can compare the effects of market volatilities on Eyepoint Pharmaceuticals and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyepoint Pharmaceuticals with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyepoint Pharmaceuticals and Checkpoint Therapeutics.
Diversification Opportunities for Eyepoint Pharmaceuticals and Checkpoint Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Eyepoint and Checkpoint is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Eyepoint Pharmaceuticals and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Eyepoint Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyepoint Pharmaceuticals are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Eyepoint Pharmaceuticals i.e., Eyepoint Pharmaceuticals and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Eyepoint Pharmaceuticals and Checkpoint Therapeutics
Given the investment horizon of 90 days Eyepoint Pharmaceuticals is expected to under-perform the Checkpoint Therapeutics. In addition to that, Eyepoint Pharmaceuticals is 1.22 times more volatile than Checkpoint Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 341.00 in Checkpoint Therapeutics on October 23, 2024 and sell it today you would lose (23.00) from holding Checkpoint Therapeutics or give up 6.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.36% |
Values | Daily Returns |
Eyepoint Pharmaceuticals vs. Checkpoint Therapeutics
Performance |
Timeline |
Eyepoint Pharmaceuticals |
Checkpoint Therapeutics |
Eyepoint Pharmaceuticals and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eyepoint Pharmaceuticals and Checkpoint Therapeutics
The main advantage of trading using opposite Eyepoint Pharmaceuticals and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyepoint Pharmaceuticals position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.Eyepoint Pharmaceuticals vs. DiaMedica Therapeutics | Eyepoint Pharmaceuticals vs. Seres Therapeutics | Eyepoint Pharmaceuticals vs. Inhibikase Therapeutics | Eyepoint Pharmaceuticals vs. Oncolytics Biotech |
Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |